Canada markets closed

Agile Therapeutics, Inc. (AGRX)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.40000.0000 (0.00%)
At close: 02:59PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
19,593
19,593
10,884
4,101
749
Cost of Revenue
8,978
8,978
6,836
10,718
282
Gross Profit
10,615
10,615
4,048
-6,617
467
Operating Expenses
Research Development
2,225
2,225
3,253
6,246
13,500
Selling General and Administrative
28,274
28,274
42,229
58,142
36,020
Total Operating Expenses
30,499
30,499
45,482
64,388
49,520
Operating Income or Loss
-19,884
-19,884
-41,434
-71,005
-49,053
Interest Expense
1,419
1,419
3,131
3,914
3,109
Total Other Income/Expenses Net
6,760
6,760
14,398
3,827
-
Income Before Tax
-14,465
-14,465
-30,087
-71,067
-51,853
Income Tax Expense
0
0
-4,675
0
0
Income from Continuing Operations
-14,465
-14,465
-25,412
-71,067
-51,853
Net Income
-14,465
-14,465
-25,412
-71,067
-51,853
Net Income available to common shareholders
-14,465
-14,465
-25,412
-71,067
-51,853
Basic EPS
7.31
-
-58.79
-1.46k
-1.22k
Diluted EPS
7.31
-
-58.79
-1.46k
-1.22k
Basic Average Shares
1,621
-
432.219
48.536
42.341
Diluted Average Shares
1,621
-
432.219
48.536
42.341